gca – -Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot 7 Results  www.roche.com
  Roche - Closing knowled...  
Show textShow cached sourceOpen source URL
Facts and figures on giant cell arteritis (GCA).
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine roche.com as primary domain
Fakten und Zahlen zur Riesenzellarteriitis.
  Roche - Closing knowled...  
Show textShow cached sourceOpen source URL
Giant cell arteritis (GCA)
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine roche.com as primary domain
Riesenzellarteriitis
  Roche - Media releases  
Show textShow cached sourceOpen source URL
Roche today announced positive results from the phase III GiACTA study, which evaluated Actemra®/RoActemra® (tocilizumab) in people with giant cell arteritis (GCA).
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine roche.com as primary domain
Roche gab heute positive Resultate der Phase-III-Studie GiACTA von Actemra®/RoActemra® (Tocilizumab) bei Patienten mit Riesenzellarteriitis (GCA) bekannt.
  Roche - Media releases  
Show textShow cached sourceOpen source URL
Phase III study shows Roche's Actemra/RoActemra maintained steroid-free remission in people with Giant Cell Arteritis (GCA)
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine roche.com as primary domain
Phase-III-Studie zeigt, dass Actemra/RoActemra von Roche die steroidfreie Remission bei Patienten mit Riesenzellarteriitis aufrechterhielt
  Roche - Immunology  
Show textShow cached sourceOpen source URL
Giant cell arteritis (GCA) is a potentially life-threatening inflammatory condition of the arteries.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine roche.com as primary domain
RA is a progressive and disabling disease. Our infographic shows how the disease affects people living with RA.
  Roche - Media releases  
Show textShow cached sourceOpen source URL
Roche today announced positive results from the Phase III study known as GiACTA, which evaluated Actemra®/RoActemra® (tocilizumab) in people with giant cell arteritis (GCA).
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine roche.com as primary domain
Roche gab heute positive Resultate der Phase-III-Studie GiACTA zur Beurteilung von Actemra®/RoActemra® (Tocilizumab) bei Patienten mit Riesenzellarteriitis bekannt.